Stevanato Group S.p.A. (STVN) Insider JR Sells $26K of Stock
A director at the medical packaging company sold roughly $25,515 worth of stock, following a flurry of activity from other executives.
Reviewed by automated data checks against the source filing. How we make and check alerts
Morel Donald JR sold 1,493 shares of Stevanato Group S.p.A. ($STVN) at an average price of $17.09, worth about $25,515.37, on June 15, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $STVN is up 1.9% after 1 week, up 13.7% after 1 month and up 13.7% to date (from the $16.63 close on Jun 15, 2026).
Key Points
- Donald Morel Jr. sold 1,493 shares of Stevanato Group on June 15, 2026, at an average price of $17.09 per share.
- The transaction follows a busy week of insider activity where three other individuals bought shares and two executives sold portions of their holdings.
- Stevanato Group shares recently traded at $18.39, placing the stock between its 52-week low of $12.89 and its yearly high of $27.99.
Get $STVN trade alerts by text
We text you when insiders, Congress or big funds trade $STVN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Stevanato Group S.p.A. alert may contain errors. Disclosures
Donald Morel Jr. sold 1,493 shares of Stevanato Group S.p.A. (STVN) on June 15, 2026. The transaction was valued at approximately $25,515, with the shares sold at an average price of $17.09. This move was disclosed in a filing with the SEC and occurred just as the stock was showing some recovery from its summer lows.
Details of the Transaction
This sale reduced Morel's position by a relatively small amount compared to the company's overall market value. The trade was not conducted under a Rule 10b5-1 plan, which is a pre-set schedule insiders often use to sell stock without appearing to time the market. While the sale is a clear exit of some capital, it represents a modest portion of the overall insider activity seen at the company throughout the month of June.
Stevanato Group Stock Performance
On Friday, the stock was priced at $18.39 on the New York Stock Exchange. The company has a market value of about $5.26 billion and its stock price has been quite volatile over the last year. Shares reached as high as $27.99 before pulling back. Currently, the stock is trading near its 200-day moving average of $18.19, a level that many traders watch to see if a stock is in a long-term uptrend or downtrend. The company's P/E ratio stands at 33.77, though its forward P/E ratio is lower at 23.18, suggesting that analysts expect profits to rise in the coming year.
Recent Earnings
Stevanato Group reported revenue of $1.23 billion in its most recent financial period, which represents a growth rate of 7.8%. The company managed to keep a net margin of 11.0% and a return on equity of 9.1%. These figures show the company is profitable, earning $0.57 per share (EPS). Investors are looking toward the next earnings announcement, which is expected to take place on November 5, 2026.
Dividend
The company pays a small dividend to its shareholders. The current annual rate provides a yield of 0.32%. Stevanato Group maintains a conservative payout ratio of 11.0%, meaning it uses only a small fraction of its total earnings to cover these dividend payments, choosing instead to reinvest the majority of its cash back into the business.
Busy Week for Insider Activity
Morel's sale was part of a larger trend of leadership trades this month. On June 12, 2026, Sue-Jean Lin, Karen Flynn, and Elisabetta Magistretti each purchased 4,975 shares. On that same day, Chief Financial Officer Dal Lago Marco sold ,7997 shares. Earlier in the month, on June 9, Chief Business Strategy Officer Mauro Stocchi both acquired and sold 6,586 shares in separate transactions. This mix of buying and selling suggests that while some leaders are cashing out, others see the current price as a good entry point.
Analysts Set New Price Targets
On September 9, 2026, UBS analysts maintained a Neutral rating on the stock but lowered their price target from $28.00 to $23.00. Despite this cautious move from UBS, the broader group of 13 analysts covering the stock remains generally positive. The average price target among these experts is $24.47, and the consensus recommendation is currently a Buy.
About Stevanato Group S.p.A.
Stevanato Group is an Italian company that specializes in making the containers and delivery systems used by the pharmaceutical industry. They produce things like pre-fillable syringes, glass vials, and pen injectors that drug companies use to package and deliver medicine to patients. Because they provide essential supplies for biotech and healthcare firms globally, their business is often tied to the overall health of the pharmaceutical manufacturing sector.
What to Watch
Investors should keep an eye on whether more insiders follow the lead of those who purchased shares on June 12. Continued buying from the board or executive team can sometimes signal internal confidence. The upcoming earnings report in November will be the next major catalyst to see if the company's 7.8% revenue growth can be sustained or accelerated. As always, these insider filings show past moves and do not necessarily reflect what these individuals are doing with their shares today.
Source: Morel Donald JR's Form 4 filing on $STVN (Jun 15, 2026). Find the original filing: STVN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
